comparemela.com

Latest Breaking News On - Euronext growth stock exchange - Page 6 : comparemela.com

PHARNEXT: Pharnext supports and participates in the First European Charcot-Marie-Tooth disease Specialists Conference

PARIS, France, June 8th, 2023, 08:30 am CET - Pharnext SA ( FR001400GUN7 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative

France generalMecklenburg vorpommernUnited statesFabreguettes leibStefan klotterEuronext growth stock exchangeFirst european charcot marie toothSpecialists conferenceFirst european conferencePresse financiStabile ertrChart profi stefan klotterBlue chips

PHARNEXT: Pharnext supports the upcoming Spring Meeting of the Neuromuscular Diseases Study Group of the Spanish Society of Neurology (SEN)

PARIS, France, May 12th, 2023, 08:30 am CET - Pharnext SA ( FR001400GUN7 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative

United statesFrance generalFabreguettes leibJavier grandaNeuromuscular diseases groupSpanish society of neurologyNeurology serviceEuronext growth stock exchangeSpring meetingNeuromuscular diseases study groupSpanish societyHospital universitario central de asturiasHospital universitario de cabuePresse financiGefallene big techs

PARIS, France, May 12th, 2023, 08:30 am CET – Pharnext SA , an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high. | May 12, 2023

United statesFrance generalJavier grandaFabreguettes leibNeurology serviceSpanish society of neurologyNeuromuscular diseases groupEuronext growth stock exchangeSpring meetingNeuromuscular diseases study groupSpanish societyHospital universitario central de asturiasHospital universitario de cabuePresse financiPharnext sa stock exchangePress release

PARIS, France, April 18th, 2023, 08:30 am CET – Pharnext SA , an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with. | April 18, 2023

United kingdomFrance generalUnited statesFabreguettes leibUnited kingdom charityEuronext growth stock exchangeFriday aprilSaturday aprilKingdom conferencePresse financiPharnext sa stock exchangePress releaseIseases alpha fr001400bv89

PHARNEXT: Pharnext supports the online 2023 Conference of CMTUK, the UK s Charity dedicated to supporting people living with Charcot-Marie-Tooth disease

PARIS, France, April 18th, 2023, 08:30 am CET - Pharnext SA (FR001400BV89 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative

United kingdomUnited statesFrance generalFabreguettes leibEuronext growth stock exchangeUnited kingdom charityFriday aprilSaturday aprilKingdom conferencePresse financi

vimarsana © 2020. All Rights Reserved.